SCHEMBL6496938

SCHEMBL6496938

COc1ccc(C2CCc3[nH]cc(C(=O)Nc4ccccn4)c3C(=O)C2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
FGFR3 P22607 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
RXFP1 Q9HBX9 2/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAP3K5 Q99683 1/20 0.38
BTK Q06187 1/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
ALOX5 P09917 1/20 0.36
SLC11A2 P49281 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494383 0.86 RXFP1 (0.40) NPC1RAB9AMEN1TP53GAA
SCHEMBL6502758 0.79 NPC1 (0.56) NPC1RAB9AMEN1TP53GAA
SCHEMBL6503748 0.78 SMN1; SMN2 (0.47) RAB9ATP53SMN1; SMN2RXFP1ALDH1A1
SCHEMBL6493715 0.76 NPC1 (0.43) NPC1RAB9AMEN1TP53GAA
SCHEMBL6497908 0.74 NPC1 (0.41) NPC1RAB9AMEN1TP53GAA
SCHEMBL7385161 0.72 BUB1 (0.49) NPC1RAB9AMEN1TP53GAA
SCHEMBL7399792 0.69 AXL (0.45) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6495856 0.67 MEN1 (0.40) NPC1RAB9AMEN1TP53GAA
SCHEMBL6501831 0.67 NPC1 (0.40) NPC1RAB9AMEN1TP53GAA
SCHEMBL70510 0.65 NPC1 (0.55) NPC1RAB9AMEN1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861529-B2 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors PFIZER INC (US) 2005-03-01 US disclosed
US-20030069416-A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives PFIZER INC. 2003-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069416-A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives GABARAP, GABRA3, GABRA2 NPC1 2192/4885RAB9A 2858/4885MEN1 4449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.